Bioequivalence Study for Acarbose/Metformin FDC

NCT04065581 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Acarbose/Metformin FDC(BAY81-9783)
DRUG: Glucobay
DRUG: Glucophage

Sponsor

Bayer